APA

Dearden C. E., Khot A., Else M., Hamblin M., Grand E., Roy A., Hewamana S., Matutes E. & Catovsky D. (20120127). Alemtuzumab therapy in T-cell prolymphocytic leukemia: comparing efficacy in a series treated intravenously and a study piloting the subcutaneous route. : Blood.

Chicago

Dearden Claire E, Khot Amit, Else Monica, Hamblin Mike, Grand Effie, Roy Ashok, Hewamana Saman, Matutes Estella and Catovsky Daniel. 20120127. Alemtuzumab therapy in T-cell prolymphocytic leukemia: comparing efficacy in a series treated intravenously and a study piloting the subcutaneous route. : Blood.

Harvard

Dearden C. E., Khot A., Else M., Hamblin M., Grand E., Roy A., Hewamana S., Matutes E. and Catovsky D. (20120127). Alemtuzumab therapy in T-cell prolymphocytic leukemia: comparing efficacy in a series treated intravenously and a study piloting the subcutaneous route. : Blood.

MLA

Dearden Claire E, Khot Amit, Else Monica, Hamblin Mike, Grand Effie, Roy Ashok, Hewamana Saman, Matutes Estella and Catovsky Daniel. Alemtuzumab therapy in T-cell prolymphocytic leukemia: comparing efficacy in a series treated intravenously and a study piloting the subcutaneous route. : Blood. 20120127.